E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedMachine draft
Standard · 3 min
The prevalence of chronic fatigue syndrome in Iceland - a national comparison by gender drawing on four different criteria.
Líndal, Eiríkur, Stefánsson, Jón G, Bergmann, Sverrir · Nordic journal of psychiatry · 2002 · DOI
Quick Summary
This study asked over 2,500 Icelanders about symptoms of chronic fatigue syndrome (CFS) to find out how many people have it. Different diagnosis criteria gave very different results—ranging from 0% to 4.9%—showing that how doctors define CFS matters a lot. The study found that women made up most of the people with CFS, and there were some interesting differences between men and women in their symptoms.
Why It Matters
This is the first prevalence study of CFS in Iceland or Scandinavia, providing epidemiological data for an understudied region. The stark variation in prevalence across diagnostic criteria highlights the critical importance of case definition standardization in CFS research and the potential for misclassification. Understanding gender differences in symptom presentation may improve diagnosis and guide patient-centered research.
Observed Findings
Prevalence of CFS using Fukuda criteria was 1.4%, but ranged from 0–4.9% across different diagnostic frameworks.
Women comprised 78% of the CFS group with mean age 44; majority were employed in unskilled work.
Males with CFS reported significantly more tinnitus (buzzing in ears) compared to females (p<0.05).
Women with CFS reported significantly higher daily food supplement use than men (p<0.01).
Males reported significantly more phobic symptoms than females (p<0.001); women with CFS had higher phobia and panic prevalence compared to healthy women (p<0.001).
Inferred Conclusions
The prevalence of CFS in Iceland is substantially influenced by which diagnostic criteria are applied, emphasizing the need for standardized case definitions.
Gender differences in symptom presentation suggest that CFS may manifest differently in men and women, with men showing more neuropsychiatric features (phobia, tinnitus) and women more likely to use dietary supplements.
The strong female predominance (78%) is consistent with other CFS epidemiological studies and warrants investigation into potential biological or sociodemographic explanations.
Remaining Questions
Why does prevalence vary so dramatically (0–4.9%) across diagnostic criteria, and which definition most accurately captures CFS biology?
What This Study Does Not Prove
This study does not establish causation regarding stress and CFS onset—participants' beliefs about stress-related onset are subjective reports, not validated evidence of etiology. The cross-sectional design cannot determine whether observed lifestyle factors (e.g., long work hours, unskilled employment) are risk factors or consequences of illness. The wide range of prevalence estimates also reflects limitations in case definition rather than true disease variation.
Tags
Symptom:Cognitive DysfunctionFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionSex-Stratified
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What explains the marked gender differences in phobic symptoms and tinnitus—are these distinct phenotypes or artifacts of reporting bias and healthcare-seeking patterns?
Does the reported stress-related onset represent true causal pathways, or does recall bias and attribution affect patient-reported etiology?
What are the long-term outcomes and functional trajectories of the identified CFS cohort, and do gender differences in symptoms predict treatment response?